Menu Search
Equities

GN Store Nord A/S

GN:CPH

GN Store Nord A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)196.15
  • Today's Change5.80 / 3.05%
  • Shares traded621.67k
  • 1 Year change-45.96%
  • Beta1.1594
Data delayed at least 15 minutes, as of Feb 08 2023 14:51 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Forecasts data is unavailable for this security.

Consensus recommendation

  • 17-Feb-22
  • 17-Nov-22
  • 15-Dec-22
  • 19-Jan-23
  • 02-Feb-23
Select bar for recommendation details.
Recommendations02-Feb-23
Buy4
Outperform8
Hold8
Underperform0
Sell0

Share price forecast in DKK

The 19 analysts offering 12 month price targets for GN Store Nord A/S have a median target of 210.00, with a high estimate of 485.00 and a low estimate of 160.00. The median estimate represents a 10.32% increase from the last price of 190.35.
High154.8%485.00
Med10.3%210.00
Low-15.9%160.00

Dividends in DKK

In 2021, GN Store Nord A/S reported a dividend of 1.55 DKK, which represents a 6.90% increase over last year. The 15 analysts covering the company expect dividends of 1.03 DKK for the upcoming fiscal year, a decrease of 33.74%.
Div growth (TTM)6.90%
More ▼

Earnings history & estimates in DKK

On Nov 11, 2022, GN Store Nord A/S reported 3rd quarter 2022 earnings of 1.54 per share.
The next earnings announcement is expected on Feb 09, 2023.
Average growth rate-9.86%
GN Store Nord A/S reported annual 2021 earnings of 13.49 per share on Feb 10, 2022.
Average growth rate+15.47%
More ▼

Revenue history & estimates in DKK

GN Store Nord A/S had 3rd quarter 2022 revenues of 4.70bn. This missed the 4.78bn consensus estimate of the 5 analysts following the company. This was 14.38% above the prior year's 3rd quarter results.
Average growth rate+6.26%
GN Store Nord A/S had revenues for the full year 2021 of 15.78bn. This was 17.29% above the prior year's results.
Average growth rate+13.37%
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.